Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 3 Aug 23 424B4 Prospectus supplement with pricing info
- 2 Aug 23 EFFECT Notice of effectiveness
- 1 Aug 23 S-1/A IPO registration (amended)
-
14 Jul 23 S-1/A IPO registration (amended)
- 30 Jun 23 S-1 IPO registration
APVO similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in this Registration Statement on Form S-1 of Aptevo Therapeutics Inc. (the “Company”) of our report dated March 30, 2023, relating to the Company’s consolidated financial statements appearing in the Annual Report on Form 10-K of the Company for the year ended December 31, 2022, filed with the Securities and Exchange Commission. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Moss Adams LLP
Seattle, Washington
July 14, 2023